Back

Impact of etiology, age and left ventricular ejection fraction on 12-month mortality effects of transcatheter edge-to-edge repair vs. surgery: a meta-regression analysis

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology (2) Mitral Valve Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emidio Mata

Unidade Local de Saude do Alto Ave - Hospital Senhora da Oliveira - Guimaraes, Creixomil (Portugal)

7 More presentations in this session

Presentation thumbnail
Comparing 30-day outcomes of transcatheter edge-to-edge repair vs surgery in mitral valve regurgitation: a meta-analysis of clinical trials and propensity-matched cohorts
Doctor B. Lage Garcia (Guimaraes, PT)
Abstract Slides Video
Presentation thumbnail
Aortic valve disease and its effect on clinical outcomes in mitral TEER patients
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Impact of baseline mitral regurgitation grade on clinical and echocardiographic outcomes following transcatheter edge-to-edge repair
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Unveiling the persistence of iatrogenic atrial septal defects after mitral transcatheter edge-to-edge repair
Doctor R. Fernandes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Innovation in mitral regurgitation therapy: a head-to-head analysis of the transcatheter edge-to-edge repair devices
Doctor T. Pereira dos Santos (Coimbra, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology (2)

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Impact of left ventricular volume and effective regurgitant orifice area on mortality effects of transcatheter edge-to-edge mitral valve repair: a meta-regression analysis
thumbnail
Congress Presentation
A meta-analysis on 12-month efficacy outcomes of transcatheter mitral valve repair vs surgery on mitral regurgitation
thumbnail
Congress Presentation
Percutaneous mitral valve repair vs surgery on 12-month mortality and hospitalizations in mitral regurgitation: a meta-analysis of clinical trials and propensity-matched cohorts

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources